THE PATHOBIOLOGY OF PULMONARY HYPERTENSION-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

THE PATHOBIOLOGY OF PULMONARY HYPERTENSION

Published:2001-09 Issue:3 Volume:22 Page:405-418
ISSN:0272-5231
Container-title:Clinics in Chest Medicine
language:en
Short-container-title:Clinics in Chest Medicine

Author:

Tuder Rubin M.,Cool Carlyne D.,Yeager Michael,Taraseviciene-Stewart Laimute,Bull Todd M.,Voelkel Norbert F.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Pulmonary and Respiratory Medicine

Reference57 articles.

1. Coagulation and fibrinolytic parameters in patients with pulmonary hypertension;Altman;Clin Cardiol,1996

2. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization;Asahara;Circ Res,1999

3. Isolation and characterization of neutralizing monoclonal antibodies to human vascular endothelial growth factor/vascular permeability factor121 (VEGF/VPF121);Asano;Hybridoma,1995

4. Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial;Badesch;Ann Intern Med,2000

5. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group;Barst;N Engl J Med,1996

Cited by 166 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging Epigenetic Targets and Their Molecular Impact on Vascular Remodeling in Pulmonary Hypertension;Cells;2024-01-28

2. Unlocking the Clinical Significance of Cytochrome P450 Enzymes;International Journal of Pharmaceutical Investigation;2023-12-27

3. Loss of Amphiregulin drives inflammation and endothelial apoptosis in pulmonary hypertension;Life Science Alliance;2022-06-22

4. The Impact of Sex Chromosomes in the Sexual Dimorphism of Pulmonary Arterial Hypertension;The American Journal of Pathology;2022-04

5. Is the Endothelium the Missing Link in the Pathophysiology and Treatment of COVID-19 Complications?;Cardiovascular Drugs and Therapy;2021-06-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3